Cargando…
Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set
OBJECTIVE: To assess the comparative utility of disability progression measures in primary progressive MS (PPMS) using the PROMiSe trial data set. METHODS: Data for patients randomized to placebo (n = 316) in the PROMiSe trial were included in this analysis. Disability was assessed using change in s...
Autores principales: | Koch, Marcus W., Cutter, Gary R., Giovannoni, Gavin, Uitdehaag, Bernard M.J., Wolinsky, Jerry S., Davis, Mat D., Steinerman, Joshua R., Knappertz, Volker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489138/ https://www.ncbi.nlm.nih.gov/pubmed/28680915 http://dx.doi.org/10.1212/NXI.0000000000000358 |
Ejemplares similares
-
A comparison of clinical outcomes in PPMS in the INFORMS original trial data set
por: Koch, Marcus W, et al.
Publicado: (2021) -
Time course of glatiramer acetate efficacy in patients with RRMS in the GALA study
por: Davis, Mat D., et al.
Publicado: (2017) -
Ocrelizumab reduces thalamic volume loss in patients with RMS and
PPMS
por: Arnold, Douglas L, et al.
Publicado: (2022) -
The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD
por: Samaraweera, Amal P.R., et al.
Publicado: (2018) -
Comparison of Disease Activity in SPMS and PPMS in the Context of Multicenter Clinical Trials
por: Orbach, Rotem, et al.
Publicado: (2012)